Home › Mallinckrodt buying Cadence Pharmaceuticals for approximately $1.21 billion
 

Keywords :   


Mallinckrodt buying Cadence Pharmaceuticals for approximately $1.21 billion

2014-02-11 17:48:35| Biotech - Topix.net

The health care products company Mallinckrodt is buying Cadence Pharmaceuticals for about $1.21 billion in a bid to strengthen its specialty drugs unit.

Tags: approximately buying billion pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11()PC-88015\"2D
23.11180&100m
23.11kenG
23.11ps3 CECH-4300C HDMI500
23.11 UNDERTALE PIANO SCORE
23.11MM6 BM11-SEC3 LC
23.11
23.11Blu-ray
More »